why choose us

First received: September 18, 2023

Clinical Trial: Left Atrial Appendage Closure With WATCHMAN FLX Device in Recurrent Gastrointestinal Bleeding: The GI-FLX Registry

Study Status: Completed

Recruit Status: RECRUITING

Condition: Atrial Fibrillation

Study Type: OBSERVATIONAL


Official Title: Left Atrial Appendage Closure With WATCHMAN FLX Device in Recurrent Gastrointestinal Bleeding: The GI-FLX Registry

Brief Summary: The GI-FLX Registry is intended to create a registry of patients with a history of Atrial Fibrillation (AF) and Gastrointestinal (GI) bleed who will receive Left Atrial Appendage Closure (LAAC) with WATCHMAN FLX device and compare to patients with AF and GI bleed who do not have LAAC.The GI-FLX Registry will be a multi-center, non-randomized registry.Approximately 250 prospective patients will be enrolled at all 4 sites.Historical cohort of 250 patients after propensity score matching with WATCHMAN-FLX arm will be…

Read more